Features of the course and treatment of bronchial asthma combined with arterial hypertension: a review

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Bronchial asthma (BA) is a serious medical and social problem. Many patients with asthma have various concomitant chronic diseases, among which the pathology of the cardiovascular system occupies an important place. Most often, asthma occurs with arterial hypertension (AH). This concurrence can lead to mutual aggravation and progression of these diseases and may negatively affect the prognosis. Usually, difficulties appear when choosing the most effective therapy for BA along with hypertension. This review aimed to analyse the available publications on the problem of the combination of BA and hypertension. A review of the literature presents the summary, examines data on prevalence and indicates risk factors for the development of hypertension among patients with asthma. The coexistence of these diseases is more typical in older people. The review includes questions regarding the pathophysiology of this comorbidity. The role of impaired gas exchange and hypoxia, endothelial dysfunction, participation of the nitric oxide system and obesity in the development of hypertension in combination with asthma are highlighted. The significance of impaired nonrespiratory lung function is shown, and the inflammation features in this comorbid pathology are indicated, as well as the contribution of numerous genes to the development of asthma along with hypertension. In the literature, 330 common genes have been identified that may be involved in the molecular mechanisms of asthma and hypertension. This study shows the effect of concomitant hypertension on the course, asthma control and quality of life of the patients. In addition, the article shows modern approaches to effective therapy with the main groups of drugs used to treat these diseases. To date, studies have demonstrated the prevalence of the combination of asthma and hypertension in the structure of comorbidity, mutual influence and aggravation of these pathologies. Coexistence of BA and hypertension increases the severity of clinical symptoms. This article shows the important aspects of the treatment of a combination of diseases. The need for a thorough assessment of the safety of pharmacological therapy for BA along with hypertension has been demonstrated.

Full Text

Restricted Access

About the authors

Irina I. Cherkashina

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Email: Cherkashina@list.ru
ORCID iD: 0000-0003-3825-3946
SPIN-code: 9715-1475

MD, Dr. Sci. (Medicine), professor

Russian Federation, Krasnoyarsk

Svetlana Yu. Nikulina

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Email: nicoulina@mail.ru
ORCID iD: 0000-0002-6968-7627
SPIN-code: 1789-3359

MD, Dr. Sci. (Medicine), professor

Russian Federation, Krasnoyarsk

Anatoly B. Averyanov

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Email: Averyanov_a007@mail.ru
ORCID iD: 0000-0002-9944-6568
SPIN-code: 1628-7431
Russian Federation, Krasnoyarsk

Maya D. Kovaleva

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Author for correspondence.
Email: mkovalyova.135@gmail.com
Russian Federation, Krasnoyarsk

References

  1. Chuchalin AG, Avdeev SN, Aisanov ZR. Federal guidelines on diagnosis and treatment of bronchial asthma. Pulmonologiya. 2022;32(3):393–447. EDN: HZEHSI doi: 10.18093/0869-0189-2022-32-3-393-447
  2. Cardet JC, Bulkhi AA, Lockey RF. Nonrespiratory comorbidities in asthma. J Allergy Clin Immunol Pract. 2021;9(11):3887–3897. doi: 10.1016/j.jaip.2021.08.027
  3. Kaplan A, Szefler SJ, Halpin DMG. Impact of comorbid conditions on asthmatic adults and children. NPJ Prim Care Respir Med. 2020;30(1):36. doi: 10.1038/s41533-020-00194-9
  4. Tiotiu A, Novakova P, Kowal K, et al. Beta-blockers in asthma: myth and reality. Expert Rev Respir Med. 2019;13(9):815–822. doi: 10.1080/17476348.2019.1649147
  5. Tomisa G, Horváth A, Sánta B, et al. Epidemiology of comorbidities and their association with asthma control. Allergy Asthma Clin Immunol. 2021;17(1):95. doi: 10.1186/s13223-021-00598-3
  6. Perelman NL. Impact of comorbid pathology on the quality of life of patients with bronchial asthma. Bulletin Physiology and Pathology of Respiration. 2022;(84):8–14. EDN: VJDAFM doi: 10.36604/1998-5029-2022-84-8-14
  7. Ostroumova OD, Goloborodova IV, Voevodina NYu, et al. Asthma and cardiovascular disease. Consilium Medicum. 2018;20(5):8–16. EDN: XVEWIP doi: 10.26442/2075-1753_2018.5.8-16
  8. Di Raimondo D, Musiari G, Benfante A, et al. Prevalence of arterial hypertension and characteristics of nocturnal blood pressure profile of asthma patients according to therapy and severity of the disease: The BADA Study. Int J Environ Res Public Health. 2020;17(18):6925. doi: 10.3390/ijerph17186925
  9. Smirnova MI, Kurekhyan AS, Gorbunov VM, et al. Prospective follow-up of hypertensive patients with concomitant chronic respiratory diseases in routine practice. Part I. Characterization of adverse events. Cardiovascular Therapy and Prevention. 2022;21(10):6–14. EDN: RCAAZO doi: 10.15829/1728-8800-2022-3383
  10. Chazova IE, Zhernakova YuV. Diagnosis and treatment of arterial hypertension [guidelines]. Systemic Hypertension. 2019;16(1):6–31. EDN: AEZOAN doi: 10.26442/2075082X.2019.1.190179
  11. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. Corrected and republished from: Eur Heart J. 2019 1;40(5):475. doi: 10.1093/eurheartj/ehy339
  12. Stafeev AN, Logvinenko NI, Melnik AV, Astrakov SV. Bronchial asthma and comorbid diseases. Variants of no synthetases genetic polymorphisms. Modern Problems of Science and Education. 2020;(4):138. EDN: LDHGGL doi: 10.17513/spno.30062
  13. Kurekhyan AS, Smirnova MI, Gorbunov VM, et al. Prevalence and characteristics of blood pressure phenotypes in patients with hypertension and chronic respiratory diseases (study of ambulatory practice data of a cardiologist). Rational Pharmacotherapy in Cardiology. 2020;16(4):542–549. EDN: JSTHHZ doi: 10.20996/1819-6446-2020-08-20
  14. Partavi MS. Peculiarities of the course and treatment bronchial asthma combined with hypertension [dissertation]. Saint Petersburg; 2022. (In Russ). EDN: QDZUYF
  15. Antonyuk MV, Gvozdenko TA, Novgorodtseva TP, et al. Features of cytokine profile in patients with bronchial asthma combined with obesity. Medicinskaja immunologija. 2018;20(6):913–920. EDN: YOOZQD doi: 10.15789/1563-0625-2018-6-913-920
  16. Chichkova NV, Gasparyan AA, Gitel EP, et al. Asthma in overweight and obese patients: assessment of adipokine profile with different fractions of adipose tissue. Prakticheskaja pul’’monologija. 2019;(3):4–9. EDN: TSHAIX
  17. Grakhova MA, Troshina IA, Zinkevich ME, Miasnikov ME. Bronchial asthma in obese patients: literature review. Medical Science and Education of Ural. 2021;22(4):172–180. EDN: KJYAEX doi: 10.36361/1814-8999-2021-22-4-172-180
  18. Chuchalin AG. A role of nitric oxide for the modern clinical practice: a scientific report at the 5th Pan-Russian Congress on pulmonary hypertension, December 13, 2017. Russian Pulmonology. 2018;28(4):503–511. EDN: VKAAKU doi: 10.18093/0869-0189-2018-28-4-503-511
  19. Kytikova OY, Antonyuk MV, Gvozdenko TA, Novgorodtseva TР. Metabolic aspects of the relationship of asthma and obesity. Obesity and Metabolism. 2018;15(4):9–14. EDN: ZAQJBJ doi: 10.14341/OMET9578
  20. Miethe S, Karsonova A, Karaulov A, Renz H. Obesity and asthma. J Allergy Clin Immunol. 2020;146(4):685–693. doi: 10.1016/j.jaci.2020.08.011
  21. Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018;141(4):1169–1179. doi: 10.1016/j.jaci.2018.02.004
  22. Kuznetsova LA, Basova NE. The role of arginine and endothelial nitric oxide synthase in the pathogenesis of Covid-19 complicated by metabolic syndrome. Acta Biomedica Scientifica. 2022;7(6): 51–70. EDN: PRBMCN doi: 10.29413/ABS.2022-7.6.6
  23. Molostova TN. Hormone-dependent asthma: past and present. Prakticheskaja pul’’monologija. 2020;(3):3–11. EDN: XULGKC
  24. Adasheva TV, Samorukova EI, Dolbin SS, et al. Approaches to treating patients with arterial hypertension and concomitant bronchopulmonary diseases (chronic obstructive pulmonary disease, asthma). Atmosfera. Novosti Kardiologii. 2022;(1):16–23. EDN: WRRUJK doi: 10.24412/2076-4189-2022-12700
  25. Zolotareva O, Saik OV, Königs C, et al. Comorbidity of asthma and hypertension may be mediated by shared genetic dysregulation and drug side effects. Sci Rep. 2019;9(1):16302. doi: 10.1038/s41598-019-52762-w
  26. Saik OV, Demenkov PS, Ivanisenko TV. Search for new candidate genes involved in the comorbidity of asthma and hypertension based on automatic analysis of scientific literature. J Integr Bioinform. 2018;15(4):20180054. doi: 10.1515/jib-2018-0054
  27. Goncharova IA, Bragina EY, Zhalsanova IZ, et al. Putative regulatory functions of SNPs associated with bronchial asthma, arterial hypertension and their comorbid phenotype. Vavilovskii Zhurnal Genet Selektsii. 2021;25(8):855–863. doi: 10.18699/VJ21.099
  28. Bragina EYu, Goncharova IA, Zhalsanova IZh, et al. Genetic comorbidity of hypertension and bronchial asthma. Arterial’naya gipertenziya. 2022;28(1):87–95. EDN: QXDOMY doi: 10.18705/1607-419X-2022-28-1-87-95
  29. Moskalenko MI, Ponomarenko IV, Polonikov AV, et al. The role of obesity in the implementation of genetic predisposition to the development of essential hypertension in men. Obesity and Metabolism. 2019;16(4):66–72. EDN: XXYMMS doi: 10.14341/omet10053
  30. Myung J, Lee H, Kim TH, et al. Relationships between self-reported asthma and pulmonary function and various measures of obesity. J Asthma. 2018;55(7):741–749. doi: 10.1080/02770903.2017.1362701
  31. Lai L, Zhang T, Zeng X, et al. Association between physician-diagnosed asthma and weight status among chinese children: the roles of lifestyle factors. Int J Environ Res Public Health. 2020;17(5):1599. doi: 10.3390/ijerph17051599
  32. Chukaeva II, Klepikova MV, Orlova NV, Agaeva LM. Role of obesity in development of hypertension and efficiency of anorectic therapy. Medical Alphabet. 2018;1(12):37–39. EDN: UQLQSQ
  33. Saliba LJ, Maffett S. Hypertensive heart disease and obesity: a review. Heart Fail Clin. 2019;15(4):509–517. doi: 10.1016/j.hfc.2019.06.003
  34. Uksumenko AA, Antonyuk MV. Pathogenetic aspects of the phenotype of bronchial asthma associated with obesity. Bulletin Physiology and Pathology of Respiration. 2019;(71):112–119. EDN: YZXVKX doi: 10.12737/article_5c89ab4f8523c5.66345570
  35. Markova TN, Fomina DS, Kostenko AA, et al. Obesity and bronchial asthma: two diseases with common aspects of pathogenesis. The Russian Journal of Preventive Medicine. 2020;23(4):126–132. EDN: HIQYPP doi: 10.17116/profmed202023041126
  36. Markova TN, Mishchenko NK, Petina DV. Adipocytokines: modern definition, classification and physiological role. Problems of Endocrinology. 2022;68(1):73–80. EDN: BWJQBG doi: 10.14341/probl12805
  37. Zhang X, Zheng J, Zhang L, et al. Systemic inflammation mediates the detrimental effects of obesity on asthma control. Allergy Asthma Proc. 2018;39(1):43–50. doi: 10.2500/aap.2018.39.4096
  38. Chong L, Liu L, Zhu L, et al. Expression levels of predominant adipokines and activations of STAT3, STAT6 in an experimental mice model of obese asthma. Iran J Allergy Asthma Immunol. 2019;18(1):62–71.
  39. Watanabe K, Suzukawa M, Arakawa S, et al. Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor. Allergol Int. 2019;68S:S3–S8. Corrected and republished from: Allergol Int. 2021;70(3):404. doi: 10.1016/j.alit.2019.04.002
  40. Grasemann H, Holguin F. Oxidative stress and obesity-related asthma. Paediatr Respir Rev. 2021;37:18–21. doi: 10.1016/j.prrv.2020.05.004
  41. Cunha CLPD. Obesity-Induced Hypertension. Arquivos Brasileiros de Cardiologia. 2023;120(7). (In Portuguese). doi: 10.36660/abc.20230391
  42. Chumakova GA, Kuznetsova TY, Druzhilov MA, Veselovskaya NG. Obesity induced hypertension: the main pathophysiological mechanisms. Arterial’naya gipertenziya. 2021;27(2):260–268. EDN: OEYVXU doi:
  43. Molchanova OV. A modern view on the prevention and treatment of arterial hypertension in obesity. The Russian Journal of Preventive Medicine. 2021;24(6):97–103. EDN: DLFXPZ doi:
  44. Andreeva GF, Smirnova MI, Gorbunov VM, et al. Seasonal indicators of blood pressure, data of asthma control questionnaires and quality of life in hypertensive patients with bronchial asthma. Rational Pharmacotherapy in Cardiology. 2019;15(6):831–839. EDN: CYULNE doi: 10.20996/1819-6446-2019-15-6-831-839
  45. Partavi MS, Emel’janov AV, Sergeeva GR, Olimova FZ. Quality of life of patients with bronchial asthma and hypertension. In: 92nd All-Russian scientific and practical conference with international participation “Mechnikov readings — 2019»; 2019 Apr 24–25; Saint Petersburg. (In Russ). EDN: PBVFAH Available from: https://elibrary.ru/item.asp?id=38503581
  46. Lin CH. Treatment of hypertension in patients with asthma. N Engl J Med. 2019;381(23):2278–2279. doi: 10.1056/NEJMc1913646
  47. Kobalava ZhD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3). EDN: TCRBRB doi: 10.15829/1560-4071-2020-3-3786
  48. Molostova TN. The use of b-blockers in patients with chronic obstructive pulmonary disease and asthma. Prakticheskaja pul’’monologija. 2018;(1):91–97. EDN: OVTGFJ

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия  ПИ № ФС 77 - 86296 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80632 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies